NICE guidance on obesity management (CG189) emphasises evidence-based interventions including dietary modification, increased physical activity, behavioural therapy, andwhere appropriatepharmacotherapy with licensed medications such as orlistat or semaglutide (NICE TA875)
Poco frecuentes: cefalea, hipertensin, hipotensin, disgeusia, dispepsia, boca seca, espasmos musculares, dolor torcico, sensacin anormal, pirexia, presin arterial aumentada
Bott AJ, Peng IC, Fan Y, Faubert B, Zhao L, Li J, Neidler S, Sun Y, Jaber N, Krokowski D, Lu W, Pan JA, Powers S, Rabinowitz J, Hatzoglou M, Murphy DJ, Jones R, Wu S, Girnun G, Zong WX (2015) Oncogenic myc induces expression of glutamine synthetase through promoter demethylation
European formulations must follow EU Regulation 1924/2006 on health and nutrition claims, and European Pharmacopoeia monographs spell out specific purity requirements
Studies suggest that Tesamorelin may specifically target the growth hormone-releasing hormone receptor (GHRHR), potentially activating the signaling cascade that leads to growth hormone synthesis and subsequent release
Front Biosci (2008) 13:721026
